Evaluating a specialized team approach for Parkinson's patients at home

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot interventional study aims to establish a multidisciplinary team, known as ESPark, to support patients with moderate to severe Parkinson's disease living at home. The study will assess the effectiveness of this specialized intervention on the quality of life of these patients. By addressing the diverse and complex needs of Parkinson's patients and their caregivers, the ESPark team seeks to improve daily living activities and overall well-being. The approach is inspired by positive outcomes from similar interventions in Alzheimer's care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

For the patient:

* Patient with a diagnosis of idiopathic Parkinson's disease
* Patient over 18 years ;
* Patient with a Hoehn and Yahr Stage greater than or equal to 3;
* Patient without major cognitive impairment defined by a MOCA score ≥21
* Patient living at home ;
* Patient with an identified non-professional primary caregiver;
* Person affiliated with or benefiting from a social security plan;
* Free, informed and and express consent (confirmed in writing) (no later than the day of inclusion and before any examination required by the research).

For the caregiver:

* Male or female over 18 years
* Able to respond to research interviews/questionnaires
* Free, informed and express consent (confirmed in writing) (no later than the day of inclusion and before any examination required by the research).

Exclusion Criteria:

For the patient:

* Patient with medically indicated dementia impairing comprehension and adherence, and/or with severe confusion or psycho-hallucinatory state;
* Institutionalized or foster care patients;
* Patients with a known severe and unstable general pathology that does not allow for patient follow-up;
* Patients already included in another non-drug management trial;
* Patients whose institutionalization is envisaged in the short term (within 6 months) or for whom a change of residence is envisaged in the short term and would not allow for follow-up assessments;
* Patients under guardianship or unable to express consent
* Primary caregiver not wishing to participate in the study or unable to be available for the planned study follow-up;
* Presence of a primary caregiver with a known severe and unstable disease that does not allow for the conduct of the study;
* Presence of a primary caregiver with a known cognitive or psychiatric disorder (chronic progressive psychosis) that does not allow for the proper conduct of the study.
* Pregnant or breastfeeding woman.

For the caregiver:

* Unable to follow the research interviews or questionnaires.
* Primary caregiver not wishing to participate in the study or unable to be available for the planned study follow-up;
* Primary caregiver with a known severe and unstable illness that does not allow for the proper conduct of the study;
* Primary caregiver with known cognitive or psychiatric disorders (chronic progressive psychosis) that do not allow the study to be conducted properly.

Where it's running

• Hopital Pellegrin
  Bordeaux, France Recruiting
• CHU de Lille
  Lille, France Recruiting
• CHU de Limoges
  Limoges, France Recruiting
• CHU Poitiers
  Poitiers, France Recruiting

Study contacts

• Principal investigator: Alexandra FOUBERT-SAMIER — University Hospital, Bordeaux
• Study coordinator: Alexandra FOUBERT-SAMIER, Dr
• Email: alexandra.samier-foubert@u-bordeaux.fr
• Phone: 05 57 82 12 53

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions

  A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT07883720

• Tributyrin for PSP: a virtual, early-phase study

  This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.

  Recruiting Phase 1/2 University of Michigan · Ann Arbor, Michigan · NCT07863180

• A look at why Lewy body conditions cause visual hallucinations

  This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.

  Recruiting NYU Langone Health · New York, New York · NCT07849413

• How physical activity might help people with Parkinson’s disease who have DBS-STN implants

  This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.

  Recruiting Medical University of Warsaw · Warsaw · NCT07838636

• Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?

  This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.

  Recruiting Klinik Valens · Valens, Canton of St. Gallen · NCT07802509

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.